Skip to Content

Avonex Sales Data

Rank 48 Current sales rank, all
U.S. Pharmaceuticals.

Last updated: February 2014 (updated quarterly).
The following data shows Avonex U.S. retail sales in Q4 2013 compared to previous quarters.

Date Range Sales Rank Sales ($000) Units (000)
Q4 2013 48 (3) -1.43% -6.67%
Q3 2013 45 (4) -6.68% -14.77%
Q2 2013 41 (2) -9.51% -9.28%
Q1 2013 39 (6) -9.05% -13.39%
Q4 2012 33 (4) -5.17% -8.94%
Q3 2012 29 (4) -5.34% -6.82%
Q2 2012 33 (6) 6.61% 1.54%
Q1 2012 39 (1) 2.22% -3.70%
Q4 2011 38 (5) 0.19% -2.17%
Q3 2011 33 -0.05% -1.43%
Q2 2011 33 (4) 2.45% -1.41%
Q1 2011 37

* Units refer to the number of packages sold.

Source: IMS Health (Midas). Please review our terms of use and attribution guidelines. Copyright - All rights reserved. Unauthorized use and/or duplication of this material without express written permission is strictly prohibited.

Related News

DateArticle
May 14, 2012New Avonex Dosing Innovations for People with Multiple Sclerosis Now Available in US
Hide